<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ital J Pediatr</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ital J Pediatr</journal-id>
      <journal-title-group>
        <journal-title>Italian Journal of Pediatrics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1824-7288</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26951087</article-id>
      <article-id pub-id-type="pmc">4782281</article-id>
      <article-id pub-id-type="publisher-id">238</article-id>
      <article-id pub-id-type="doi">10.1186/s13052-016-0238-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Kawasaki disease and hepatobiliary involvement: report of two cases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2971-8422</contrib-id>
          <name>
            <surname>Keeling</surname>
            <given-names>Ingeborg Marianne</given-names>
          </name>
          <address>
            <phone>(++43)-316-385-12820</phone>
            <email>ingeborg.keeling@medunigraz.at</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Beran</surname>
            <given-names>Elisabeth</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dapunt</surname>
            <given-names>Otto Eugen</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department Cardiac Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036 Graz, Austria </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>42</volume>
      <elocation-id>27</elocation-id>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>2</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Keeling et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Kawasaki disease (KD) without affection of the coronary artery system is rare. Optic nerve pathology together with KD has not been described earlier.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We present one case of KD in a 12-year-old girl predominantly with prolonged cholestasis, and a second case of multiple recurrent KD in a 9-year-old boy with hepatomegaly and ischemic optic nerve neuropathy. The coronary artery system was not involved in either case.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>KD warrants rapid diagnosis and immediate specific treatment in order to prevent the high risk of coronary artery aneurysm and stenosis.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Kawasaki disease</kwd>
        <kwd>Hepatopathy</kwd>
        <kwd>Cholestasis</kwd>
        <kwd>Ischemic optic nerve neuropathy</kwd>
        <kwd>Differential diagnosis</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Various manifestations of Kawasaki disease (KD) occur at an early age. When the hepatobiliary tract is primarily affected, the diagnosis relies mainly on symptoms, ultrasonography and laboratory parameters of systemic vasculitis. Numerous diseases must be excluded. Incomplete and atypical cases are difficult to detect. Rapid diagnosis and treatment are crucial, as 4&#xA0;% of KD patients develop coronary artery (CA) involvement [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <sec id="Sec3">
        <title>Case 1</title>
        <p>A 12-year-old girl presented with a 6-day history of subfebrile temperature, generalized lymphadenitis, fatigue and inappetence. Exanthema of the extremities and trunk, raspberry tongue, bulbar injection, facial edema, palmar erythema, swelling of the small-finger joints, discrete jaundice and epigastric tenderness were observed. The general practitioner (GP) had treated her (benzathin-phenoxymethyl penicillin, 750&#xA0;mg TID) for suspected scarlet fever.</p>
        <p>Laboratory data (and normal range in parenthesis) were: WBCC 15 400/mm<sup>3</sup> (4 500&#x2013;12 000/mm<sup>3</sup>), PMN cells 73.4&#xA0;% (50.0&#x2013;75.0&#xA0;%), lymphocytes 9.4&#xA0;% (20.0&#x2013;40.0&#xA0;%), eosinophils 9.0&#xA0;% (0&#x2013;5.0&#xA0;%), platelets 451 000/mm<sup>3</sup> (140 000&#x2013;440 000/mm<sup>3</sup>), CRP 15&#xA0;mg/l (0&#x2013;8&#xA0;mg/l), ASL 971U/ml (0&#x2013;125U/ml), total bilirubin 5.37&#xA0;mg/dl (0&#x2013;1.30&#xA0;mg/dl), esterized bilirubin 2.86&#xA0;mg/dl (&lt;0.20&#xA0;mg/dl), ASAT 17U/l (0&#x2013;21U/l), ALAT 42U/l (0&#x2013;22U/l), GGT 50U/l (0&#x2013;19U/l), AP 557U/l (0&#x2013;390U/l), HDL cholesterol 5&#xA0;mg/dl (&#x2265;37&#xA0;mg/dl), bilirubinuria, and ketonuria. Hepatitis screening revealed borderline complement binding reaction for Enterovirus and Coxsackievirus types other than A9. The chest x-ray showed prominent hila and the ECG a normofrequent sinus rhythm. Echocardiography indicated normal left ventricular function. CAs had normal dimension, no signs of aneurysm. Liver ultrasonography revealed distinct periportal fields. Clinical symptoms suggested KD with uncommon cholestasis. On the day of admission, treatment was started with intravenous immune globulin (IVIG) (Octagam&#xAE;, 1.6&#xA0;g/kg/d), aspirin (ASA, 500&#xA0;mg TID), sucralfate (1&#xA0;g TID), and ursodeoxycholic acid (100&#xA0;mg TID).</p>
        <p>Desquamation of the fingertips and pronounced jaundice developed. The blunt liver margin was palpated 0.5&#x2013;1&#xA0;cm underneath the right costal edge and hepatic consistency was found normal. Moderately acholic stools and hyperchromic urines were noted. Ultrasonography and MRI showed hepatomegaly (13x16x9.6&#xA0;cm) and regular width of intra- and extrahepatic bile ducts. After 10&#xA0;days, the patient improved and was discharged with ASA treatment.</p>
        <p>Immunologic screening revealed positive anti-Ro-antibodies and a positive anti-U<sub>1</sub>-snRNP subset (against extractable nuclear antigen-ribonucleoprotein). Four months after discharge, transaminases and platelet counts normalized while total cholesterol (249&#xA0;mg/dl, normal &lt;200&#xA0;mg/dl) and eosinophils (11.1&#xA0;%, normal 0&#x2013;5.0&#xA0;%) remained elevated.</p>
      </sec>
      <sec id="Sec4">
        <title>Case 2</title>
        <p>Since his fourth month of life, a 9-year-old boy experienced upper respiratory infections and recurrent otitis.</p>
        <p>At the age of 4&#xA0;years he was admitted 5&#xA0;days after headaches, conjunctival injection, fever, fatigue, enanthema of the throat and tonsils, raspberry tongue and enlargement of submandibular lymph nodes evolved. Laboratory results were: WBCC 27 300/mm<sup>3</sup>, (4 500&#x2013;12 000/mm<sup>3</sup>), platelets 594 999/mmm<sup>3</sup> (140 000&#x2013;440 000/mm<sup>3</sup>), CRP 25&#xA0;mg/l (0&#x2013;8&#xA0;mg/l), ESR 60/96 (3&#x2013;13&#xA0;mm/1&#xA0;h), ASL and RF negative. Although an exanthema was missing, clinical findings suggested incomplete KD. Treatment consisted of IVIG (Octagam&#xAE;, 2&#xA0;g/kg/d), and high-dose ASA (300&#xA0;mg QID) for 3&#xA0;weeks. Fever resolved within 24&#xA0;h. Desquamation of the toes developed upon discharge.</p>
        <p>After persistent fever for 10&#xA0;days at age 6&#xA0;years, resistant to antibiotic treatment occurred along with repeated vomiting, fatigue, angina, headaches, photophobia, raspberry tongue and desquamation of the toes. Laboratory data were: WBCC 21 800/mm<sup>3</sup>, platelets 746 000/mm<sup>3</sup>, CRP 22&#xA0;mg/l, ESR 110&#xA0;mm/1&#xA0;h. Recurrent incomplete KD was diagnosed. The child developed intolerance to IVIG (Endobulin&#xAE;, 5&#xA0;g), with severe abdominal pains. The liver margin was palpable 0.5&#xA0;cm below the right costal edge, hepatic consistency was normal. Stool and urine were unremarkable. Only once during the hospital stay ASAT 26U/l (0&#x2013;21U/l) and ALAT 23U/l (0&#x2013;22U/l) were slightly elevated. CT showed hepatomegaly, a prominent, homogenous pancreas, and reflections, possibly small sedimentations, in the choledochus duct. The examination neither confirmed nor dismissed an autoimmune disease. Reduced tissue necrosis factor (TNF)&#x2013;receptor levels (0.81&#xA0;ng/ml; 50&#xA0;% of the minimum norm) suggested autosomal-dominant TNF-receptor associated periodic fever syndrome (TRAPS), but exon 2&#x2013;5 mutations of the TNFR1A1 gene were not found in PCR.</p>
        <p>At the age of 9&#xA0;years the patient was admitted for acute right-sided ablepsia. The ophthalmologist diagnosed ischemic optic nerve neuropathy. High-dose steroids for 13&#xA0;days incompletely restored the child&#x2019;s vision. The examination for an autoimmunologic disease was negative.</p>
      </sec>
    </sec>
    <sec id="Sec5">
      <title>Conclusions</title>
      <p>In both exposed cases, KD was strongly suggested at admission. Uncommon clinical features in these two children were hepatopathy, cholestasis and diarrhea. In case 1, hepatomegaly and cholestasis, with distinct periportal fields, were identified by ultrasonography and MRI. In case 2, hepatomegaly with cholangitis was present. The CA system was unaffected. The predominant gastrointestinal manifestation in up to 13.9&#xA0;% of KD cases is acalculous gallbladder hydrops, which may require cholecystectomy or percutaneous transhepatic biliary drainage [<xref ref-type="bibr" rid="CR2">2</xref>]. Hepatopathy exceptionally rarely induces hepatocellular necrosis [<xref ref-type="bibr" rid="CR3">3</xref>]. Other manifestations include hepatitis, pancreatitis, enteritis and ileus. Gilbert&#x2019;s syndrome with concurrent infection may resemble KD in clinical terms.</p>
      <p>Childhood diseases like scarlet fever may manifest symptoms of hepatopathy and cholestasis. Coxsackievirus and Enterovirus associated hepatopathy were unlikely, as cholestasis without hepatitis, and elevated ESR and PMN are usually unrelated to these viral infections. In any case, KD-related macrophage activation syndrome (MAS) should be also suspected if liver dysfunction presents with other typical abnormal laboratory findings, such as cytopenia, hyperferritinemia and elevated serum LDH.</p>
      <p>Initial antibiotic treatment for suspected bacterial infection, as in the present case, renders drug side-effects an important differential diagnosis. In case 1, where positive Ro-antibodies, extractable nuclear antigen-ribonucleoprotein (U<sub>1</sub>-snRNP), and elevated eosinophils suggested autoimmune hepatopathy rather than penicillin reaction, jaundice subsided without treatment 5&#xA0;weeks post-discharge.</p>
      <p>Toxic shock syndrome (TSS) may mimic KD. A connection between staphylococcal and streptococcal TTS and KD has also been suggested [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>Specific immunologic alterations may be found in KD, which requires extensive immunologic testing and the use of image processing to confirm KD diagnosis. Therefore, in complex KD cases multispecialist approach, including the pediatric cardiologist, immunologists, rheumatologist, hepatologist, infectiologist, ophthalmologist, intensive care personnel, and clinical pharmacologist, are essential to avoid the many pitfalls of rapid diagnosis.</p>
      <p>KD patients with fever, CRP&#x2009;&gt;10&#xA0;mg/dl, LDH&#x2009;&gt;590U/l and/or hemoglobin&#x2009;&lt;10&#xA0;g/dl, and those with high bilirubin and transaminases, are considered non-responsive to IVIG [<xref ref-type="bibr" rid="CR4">4</xref>]. IVIG resistance with persistent or recrudescent fever occurs in approximately 18&#xA0;% of KD patients. Retreatment involved more individual adjustment, consisting of intravenous steroid pulse therapy, infliximab, cyclophosphamide, anakinra, etanercept, methotrexate, or plasmapheresis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>&#x2013;<xref ref-type="bibr" rid="CR6">6</xref>]. Additionally, antioxidants, as vitamin C, and drugs affecting cholesterol levels, can reduce endothelial dysfunction.</p>
      <p>Abnormalities of liver function tests are frequently found in patients with acute KD. Indeed, children with abnormal liver function tests are at higher risk for IVIG resistance [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Moreover, ultrasonographic biliary findings or higher AST levels may be risk factors for coronary artery abnormality as a complication and/or recurrent KD if they are present during the first episode [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p>
      <p>After repeated KD episodes, case 2 developed an extremely rare ophthalmologic KD manifestation, specifically ischemic optic nerve neuropathy, which to our knowledge is the first reported case of optic nerve pathology associated with KD [<xref ref-type="bibr" rid="CR11">11</xref>]. However, transient affliction of the cranial nerves may at times be either the presenting feature or a complication of an otherwise uncomplicated KD in infants and children. Oculomotor nerve palsy may resolve after IVIG therapy [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
      <p>In conclusion, atypical KD calls for extreme alertness, rapid diagnosis and immediate treatment if suggested. The absence of CA lesions and the presence of cholestasis may delay the diagnosis and specific treatment of this potentially life-threatening disease with severe long-term consequences.</p>
      <sec id="Sec6">
        <title>Consent</title>
        <p>Written informed consent was obtained from the parents of the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>GP</term>
          <def>
            <p>general practitioner</p>
          </def>
        </def-item>
        <def-item>
          <term>TID</term>
          <def>
            <p>three times per day</p>
          </def>
        </def-item>
        <def-item>
          <term>QID</term>
          <def>
            <p>four times per day</p>
          </def>
        </def-item>
        <def-item>
          <term>ASL titer</term>
          <def>
            <p>antistreptolysine titer</p>
          </def>
        </def-item>
        <def-item>
          <term>WBCC</term>
          <def>
            <p>white blood cell count</p>
          </def>
        </def-item>
        <def-item>
          <term>PMN</term>
          <def>
            <p>polymorphonuclear</p>
          </def>
        </def-item>
        <def-item>
          <term>CRP</term>
          <def>
            <p>C-reactive protein</p>
          </def>
        </def-item>
        <def-item>
          <term>ESR</term>
          <def>
            <p>blood sedimentation rate</p>
          </def>
        </def-item>
        <def-item>
          <term>ATIII</term>
          <def>
            <p>antithrombin III</p>
          </def>
        </def-item>
        <def-item>
          <term>ASAT</term>
          <def>
            <p>aspartate amino transferase</p>
          </def>
        </def-item>
        <def-item>
          <term>ALAT</term>
          <def>
            <p>alanine amino transferase</p>
          </def>
        </def-item>
        <def-item>
          <term>GGT</term>
          <def>
            <p>&#x3B3;-glutamyl transferase</p>
          </def>
        </def-item>
        <def-item>
          <term>AP</term>
          <def>
            <p>alkaline phosphatase</p>
          </def>
        </def-item>
        <def-item>
          <term>HDL</term>
          <def>
            <p>high-density lipoprotein</p>
          </def>
        </def-item>
        <def-item>
          <term>RBCC</term>
          <def>
            <p>red blood cell count</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>magnetic resonance imaging</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>IMK wrote the manuscript, EB and OED contributed valuable discussion. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;nchez-Manubens</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bou</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Anton</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and classification of Kawasaki disease</article-title>
          <source>J Autoimmun</source>
          <year>2014</year>
          <volume>48&#x2013;49</volume>
          <fpage>113</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jaut.2014.01.010</pub-id>
          <pub-id pub-id-type="pmid">24485156</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zulian</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Falcini</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zancan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Martini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Secchieri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Luzzatto</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zacchello</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Acute surgical abdomen as presenting manifestation of Kawasaki disease</article-title>
          <source>J Pediatr</source>
          <year>2003</year>
          <volume>142</volume>
          <fpage>731</fpage>
          <lpage>735</lpage>
          <pub-id pub-id-type="doi">10.1067/mpd.2003.232</pub-id>
          <pub-id pub-id-type="pmid">12838207</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Majumdar</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Kawasaki disease masquerading as hepatitis: a diagnostic challenge for pediatricians</article-title>
          <source>Clin Pediatr</source>
          <year>2016</year>
          <volume>55</volume>
          <fpage>73</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1177/0009922815569206</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newburger</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gerber</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Gewitz</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Tani</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>JC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in The Young, American Heart Association</article-title>
          <source>Pediatr</source>
          <year>2004</year>
          <volume>114</volume>
          <fpage>1708</fpage>
          <lpage>1733</lpage>
          <pub-id pub-id-type="doi">10.1542/peds.2004-2182</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hashkes</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Cabral</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Laxer</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Paller</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Rabinovich</surname>
              <given-names>CE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Methotrexate: new uses for an old drug</article-title>
          <source>J Pediatr</source>
          <year>2014</year>
          <volume>164</volume>
          <fpage>231</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jpeds.2013.10.029</pub-id>
          <pub-id pub-id-type="pmid">24286573</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Chiou</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>RC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Late diagnosis of Kawasaki disease is associated with haptoglobin phenotype</article-title>
          <source>Eur J Clin Invest</source>
          <year>2000</year>
          <volume>30</volume>
          <fpage>379</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2362.2000.00646.x</pub-id>
          <pub-id pub-id-type="pmid">10809897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eladawy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dominguez</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Glod&#xE9;</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Abnormal liver panel in acute kawasaki disease</article-title>
          <source>Pediatr Infect Dis J</source>
          <year>2011</year>
          <volume>30</volume>
          <fpage>141</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1097/INF.0b013e3181f6fe2a</pub-id>
          <pub-id pub-id-type="pmid">20861758</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="other">Liu L, Yin W, Wang R, Sun D, He X, Ding Y. The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis. Inflamm Res 2015 Dec 8 [Epub ahead of print].</mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yi</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>EY</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children</article-title>
          <source>BMC Pediatr</source>
          <year>2014</year>
          <volume>14</volume>
          <fpage>51</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2431-14-51</pub-id>
          <pub-id pub-id-type="pmid">24548331</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>ZD</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>PP</given-names>
            </name>
          </person-group>
          <article-title>Clinical features of recurrent Kawasaki disease and its risk factors</article-title>
          <source>Eur J Pediatr</source>
          <year>2013</year>
          <volume>172</volume>
          <fpage>1641</fpage>
          <lpage>1647</lpage>
          <pub-id pub-id-type="doi">10.1007/s00431-013-2101-9</pub-id>
          <pub-id pub-id-type="pmid">23887608</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anand</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>YC</given-names>
            </name>
          </person-group>
          <article-title>Optic disc changes in Kawasaki disease</article-title>
          <source>J Pediatr Ophthalmol Strabismus</source>
          <year>2004</year>
          <volume>41</volume>
          <fpage>177</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="pmid">15206604</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thapa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mallick</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Biswas</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chakrabartty</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Transient unilateral oculomotor palsy and severe headache in childhood Kawasaki disease</article-title>
          <source>Rheumatol Int</source>
          <year>2011</year>
          <volume>31</volume>
          <fpage>97</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1007/s00296-009-1154-6</pub-id>
          <pub-id pub-id-type="pmid">19823842</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
